THE EFFECT OF GUSELKUMAB ON ENTHESITIS: RESULTS FROM A PHASE 2 STUDY IN PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS

被引：1
|
作者：
Helliwell, P. [1 ]
Gottlieb, A. B. [2 ]
Deodhar, A. [3 ]
Boehncke, W. -H. [4 ]
McGonagle, D. [1 ]
Xu, X. L. [5 ]
Xu, S. [5 ]
Wang, Y. [5 ]
Hsia, E. C. [5 ,6 ]
Karyekar, C. S. [7 ]
Mease, P. [8 ,9 ]
机构：
[1] Univ Leeds, Leeds, W Yorkshire, England
[2] Metropolitan Hosp, NY Med Coll, New York, NY USA
[3] Oregon Hlth & Sci Univ, Portland, OR 97201 USA
[4] Univ Geneva, Geneva, Switzerland
[5] Janssen Res & Dev LLC, Spring House, PA USA
[6] Univ Penn, Philadelphia, PA USA
[7] Janssen Sci Affairs LLC, Horsham, PA USA
[8] Swedish Med Ctr, Seattle, WA USA
[9] Univ Wash, Seattle, WA USA
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2018年 / 77卷
关键词：
D O I：
10.1136/annrheumdis-2018-eular.5460
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
SAT0344
引用
收藏
页码：1037 / 1037
页数：1
相关论文
共 50 条
  • [41] Guselkumab (TREMFYA®) Provides Consistent and Durable Pain Improvement in Patients with Active Psoriatic Arthritis: Results of 2 Phase 3, Randomized, Controlled Clinical Trials
    Nash, Peter
    Tam, Lai-Shan
    Tsai, Wen-Chan
    Leung, Ying-Ying
    Furtner, Daniel
    Sheng, Shihong
    Wang, Yanli
    Shawi, May
    Kollmeier, Alexa
    Sherlock, Jonathan
    Cua, Daniel
    ARTHRITIS & RHEUMATOLOGY, 2021, 73 : 2769 - 2772
  • [42] THE EFFECT OF FILGOTINIB ON ENTHESITIS: 100-WEEK DATA FROM AN OPEN-LABEL EXTENSION STUDY IN PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS
    Helliwell, P.
    Coates, L. C.
    Van den Bosch, F.
    Gladman, D. D.
    Gheyle, L.
    Trivedi, M.
    Alani, M.
    Le Brun, F. O.
    Besuyen, R.
    Mease, P. J.
    ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 792 - 793
  • [43] Enthesitis in patients with psoriatic arthritis: A nationwide data from the Chinese Registry of Psoriatic Arthritis (CREPAR)
    Yang Fan
    Lu Chaofan
    Liu Huilan
    Dou Lei
    Wang Yanhong
    Li Hongbin
    Duan Xinwang
    Wu Lijun
    Wang Yongfu
    Zhang Xiuying
    Xu Jian
    Su Jinmei
    Xu Dong
    Zhao Jiuliang
    Wu Qingjun
    Li Mengtao
    Leng Xiaomei
    Zeng Xiaofeng
    中华医学杂志英文版, 2023, 136 (08)
  • [44] EFFECT OF FILGOTINIB ON PATIENT-REPORTED OUTCOMES IN ACTIVE PSORIATIC ARTHRITIS: RESULTS FROM EQUATOR, A RANDOMIZED, PHASE 2 STUDY
    Coates, Laura C.
    Mease, Philip J.
    Gladman, Dafna D.
    van den Bosch, Filip
    Tasset, Chantal
    Meuleners, Luc
    Besuyen, Robin
    Gao, Jingjing
    Trivedi, Mona
    Hendrikx, Thijs
    Helliwell, Philip
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 1269 - 1270
  • [45] Enthesitis in patients with psoriatic arthritis: A nationwide data from the Chinese Registry of Psoriatic Arthritis (CREPAR)
    Yang, Fan
    Lu, Chaofan
    Liu, Huilan
    Dou, Lei
    Wang, Yanhong
    Li, Hongbin
    Duan, Xinwang
    Wu, Lijun
    Wang, Yongfu
    Zhang, Xiuying
    Xu, Jian
    Su, Jinmei
    Xu, Dong
    Zhao, Jiuliang
    Wu, Qingjun
    Li, Mengtao
    Leng, Xiaomei
    Zeng, Xiaofeng
    CHINESE MEDICAL JOURNAL, 2023, 136 (08) : 951 - 958
  • [46] IZOKIBEP (ABY-035) IN PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS-16-WEEK RESULTS FROM A PHASE 2 STUDY
    Behrens, F.
    Taylor, P. C.
    Wetzel, D.
    Brun, N. C.
    Brandt-Juergens, J.
    Drescher, E.
    Dokoupilova, E.
    Rowinska-Osuch, A.
    Martin, N. Abdel-Kader
    de Vlam, K.
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 170 - 171
  • [47] Impact of guselkumab, an interleukin-23 p19 subunit inhibitor, on enthesitis and dactylitis in patients with moderate to severe psoriatic arthritis: results from a randomised, placebo-controlled, phase II study
    Mease, Philip J.
    Gladman, Dafna D.
    Deodhar, Atul
    McGonagle, Dennis G.
    Nash, Peter
    Boehncke, Wolf-Henning
    Gottlieb, Alice
    Xu, Xie L.
    Xu, Stephen
    Hsia, Elizabeth C.
    Karyekar, Chetan S.
    Helliwell, Philip S.
    RMD OPEN, 2020, 6 (02):
  • [48] Effect of Filgotinib on the Complete Resolution of Enthesitis in Psoriatic Arthritis (PsA) Patients: 52-week Results from EQUATOR2
    Mease, Philip
    Coates, Laura
    Van den Bosch, Filip
    Helliwell, Philip
    Gladman, Dafna
    Gilles, Leen
    Gheyle, Lien
    Trivedi, Mona
    Alani, Muhsen
    Besuyen, Robin
    ARTHRITIS & RHEUMATOLOGY, 2020, 72
  • [49] Efficacy and Safety of Ixekizumab in Patients with Active Psoriatic Arthritis: 52 Week Results from a Phase 3 Study
    Mease, Philip J.
    Okada, Masato
    Kishimoto, Mitsumasa
    Shuler, Catherine L.
    Carlier, Hilde
    Lin, Chen-Yen
    Mou, Jiani
    Moriarty, Susan R.
    Lee, Chin H.
    Gladman, Dafna D.
    ARTHRITIS & RHEUMATOLOGY, 2016, 68
  • [50] Effects of guselkumab on musculoskeletal features in patients with active psoriatic arthritis by baseline skin disease: Results from the phase 3 DISCOVER-1 and DISCOVER-2 studies
    Gottlieb, Alice B.
    Mease, Philip
    Rahman, Proton
    Kollmeier, Alexa P.
    Zhou, Bei
    McInnes, Iain B.
    Deodhar, Atul
    Helliwell, Philip
    Ritchlin, Christopher T.
    Boehncke, Wolf-Henning
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2020, 83 (06) : AB36 - AB36
12345